Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Biochemical Reagents
  4. Nucleosides and Analogues
  5. Purine nucleotides
  6. MP021502615

Adenosine-5'-Diphosphate Trilithium Salt Hydrate, MP Biomedicals™

Catalog Number MP021502615
Click to view available options
Quantity:
500 mg
31008-64-7
C10H12Li3N5O10P2
445.00
MFCD00065469
LZGPPAHUZSOGHJ-DJXXCMMGNA-K
adenosine-5'-diphosphate trilithium salt, adenosine 5'-trihydrogen diphosphate , trilithium salt, adp-li3, trilithium 1+ adenosine 5'-diphosphate, adenosine 5'-diphosphate trilithium salt, adenosine 5'-diphosphate,trilithium salt, adenosine-5'-diphosphate, trilithium salt, trilithium 1+ ion adenosine 5'-diphosphate, adenosine 5'-diphosphoric acid trilithium salt, adenosine-5'-diphosphate,trilithium salt
56841973
trilithium(1+) ({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphonato}oxy)phosphonate
[Li+].[Li+].[Li+].NC1=C2N=CN([C@@H]3O[C@H](COP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]3O)C2=NC=N1
31008-64-7
C10H12Li3N5O10P2
445.00
MFCD00065469
LZGPPAHUZSOGHJ-DJXXCMMGNA-K
adenosine-5'-diphosphate trilithium salt, adenosine 5'-trihydrogen diphosphate , trilithium salt, adp-li3, trilithium 1+ adenosine 5'-diphosphate, adenosine 5'-diphosphate trilithium salt, adenosine 5'-diphosphate,trilithium salt, adenosine-5'-diphosphate, trilithium salt, trilithium 1+ ion adenosine 5'-diphosphate, adenosine 5'-diphosphoric acid trilithium salt, adenosine-5'-diphosphate,trilithium salt
56841973
trilithium(1+) ({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphonato}oxy)phosphonate
[Li+].[Li+].[Li+].NC1=C2N=CN([C@@H]3O[C@H](COP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]3O)C2=NC=N1

Description

Adenosine-5'-Diphosphate Trilithium Salt Hydrate, MP Biomedicals is a lithium salt formulation of the essential metabolic compound ADP.

Adenosine 5′-diphosphate has been used to study the release, neuronal effects and removal of extracellular β-nicotinamide adenine dinucleotide (β-NAD+) in the rat brain. Adenosine 5′-diphosphate has also been used to compare prasugrel versus clopidogrel antiplatelet therapy after acute coronary syndrome.

Refractive Index ∼1.90 (Predicted) (Lit.)
Quantity 500 mg
Formula Weight 445 (anhydrous)
Percent Purity ≥96%
Physical Form Powder

Safety and Handling

Recommended Storage Store at –20°C
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit